 heart rate variabl patient ventricular arrhythmia effect antiarrhythm drug antiarrhythm drug evalu group adeg purpos studi heart rate variabl patient ventricular arrhythmia antiarrhythm drug studi analysi ambulatori electrocardiograph ecg record patient frequent complex ventricular arrhythmia antiarrhythm drug evalu group adeg studi record exclus prematur ventricular complex number time period consecut sinu RR interv ms total count record index heart rate variabl method reliabl marker cardiac parasympathet activ record baselin long-term treatment amiodaron propafenon washout patient presenc differ number arrhythmia total count patient reproduc time differ record baselin count median rang number arrhythmia antiarrhythm drug dispar effect total count chang patient amiodaron median percent chang delta NS signific decreas patient flecainid median delta propafenon median delta